Get The App!
Loading the player...
Is the Rate of MPN Leukemic Transformation (ie, BP-MPN) Affected by Prior Therapy?
Share by Email
Send to social websites
Report this video as inappropriate
You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email.
Select your reason
Violent or Repulsive Content
Hateful or Abusive Content
Harmful Dangerous Acts
Dr. John Mascarenhas, Mt. Sinai School of Medicine, answers the following question: Is the rate of MPN leukemic transformation (ie, BP-MPN) affected by prior therapy?
Are There Certain Genetic Alterations That May Help Identify Patients at Risk for Imminent Leukemic ...
For HSCT Candidates with Advancing MF, What are Their Chief Reasons for Electing Not to Undergo Tran...
Do Patients Ever Present with >5% Peripheral Blasts at Diagnosis?
If Peripheral Blasts Increase While on Ruxolitinib, is That Considered Treatment Failure?
Are There Different Types of Blasts in the Peripheral Blood, and What Do They Mean for a Patient wit...
Do You Routinely Monitor Patients for Signs of Leukemic Transformation (eg, JAK2 Allele Burden)?
Does Progression to Accelerated or Blast-Phase MF Increase Patient's Splenomegaly/ Symptom Burden?
In Patients with PV, What Clinical Triggers Would Lead You to Perform a Bone Marrow Biopsy?
Copyright 2020 by NSCI Group, Inc.
On The Go
About MedEd On The Go